I like this part from the last PR. The

I like this part from the last PR.

The clinical trials in Bulgaria (Referred to as EU) are scheduled to begin in May 2013 and end in October 2013, which will give Immunotech, the rights to receive approval for applications of the "IPF" Treatment. In this respect, Immunotech Laboratories BG has had a series of conversations with Mr. Vladimir Stoichev, the Deputy General Director from Sopharma Bulgaria, and the parties have had talks for the possible signing of a contract between Immunotech Laboratories BG and Sopharma for joint production of IPF-ITV. Sopharma is a leading pharmaceutical company in the European Union. This is going to be HUGE!